Sebastián Rufián-Peña

Suggest Changes
Learn More
BACKGROUND Cytoreductive surgery with peritonectomy procedures and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) represents a radical therapeutic approach to achieve complete cytoreduction(More)
BACKGROUND This study evaluated the use of TachoSil as an adjunctive therapy for reducing axillary lymphocele formation. METHODS Eighty-six patients diagnosed with breast cancer N+ and treated with(More)
BACKGROUND The acute renal dysfunction (ARD) is a common complication in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Our aim is evaluate the ARD post-HIPEC procedures(More)
BACKGROUND The cytoreductive surgery (CRS) associated with hyperthermic intraperitoneal chemotherapy (HIPEC) has become the standard treatment in patients with carcinomatosis peritoneal from(More)
BACKGROUND Pseudomyxoma peritonei (PMP) is a rare, slowly progressive disease whose prognosis depends primarily on the completeness of cytoreduction. The value of intraoperative hyperthermic(More)